These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25053372)

  • 1. A longitudinal study of factor XIII activity, fibrinogen concentration, platelet count and clot strength during normal pregnancy.
    Karlsson O; Jeppsson A; Hellgren M
    Thromb Res; 2014 Sep; 134(3):750-2. PubMed ID: 25053372
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective, sequential, longitudinal study of coagulation changes during pregnancy in Chinese women.
    Liu XH; Jiang YM; Shi H; Yue XA; Wang YF; Yang H
    Int J Gynaecol Obstet; 2009 Jun; 105(3):240-3. PubMed ID: 19342052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM).
    Theusinger OM; Baulig W; Asmis LM; Seifert B; Spahn DR
    Thromb Haemost; 2010 Aug; 104(2):385-91. PubMed ID: 20431856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudofibrinolysis in the thrombelastogram, factor XIII and fibrinogen split products in the 2nd half of normal pregnancy, during labor, and puerperium (author's transl)].
    Riedel H; Barthels M; Trobisch H
    Z Geburtshilfe Perinatol; 1973 Oct; 177(5):339-49. PubMed ID: 4777491
    [No Abstract]   [Full Text] [Related]  

  • 5. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both?
    Karlsson O; Jeppsson A; Hellgren M
    Int J Obstet Anesth; 2014 Feb; 23(1):10-7. PubMed ID: 24342222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Packaging zinc, fibrinogen, and factor XIII in platelet alpha-granules.
    Marx G; Korner G; Mou X; Gorodetsky R
    J Cell Physiol; 1993 Sep; 156(3):437-42. PubMed ID: 8360253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation assessment by rotation thrombelastometry in normal pregnancy.
    Huissoud C; Carrabin N; Benchaib M; Fontaine O; Levrat A; Massignon D; Touzet S; Rudigoz RC; Berland M
    Thromb Haemost; 2009 Apr; 101(4):755-61. PubMed ID: 19350122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
    Choi JW; Pai SH
    Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the properties of fibrinogen as a result of blood loss].
    Zhankina GKh
    Vestn Khir Im I I Grek; 1972 Sep; 109(9):80-3. PubMed ID: 4664064
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On fibrinolysis and coagulation during parturition and menstruation.
    Hahn L
    Acta Obstet Gynecol Scand Suppl; 1974; 28():7-40. PubMed ID: 4599650
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of the fibrinogen gamma' chain: implications for the binding of factor XIII, thrombin and platelets.
    Doolittle RF; Hong S; Wilcox D
    J Thromb Haemost; 2009 Aug; 7(8):1431-3. PubMed ID: 19552683
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective longitudinal study on rotation thromboelastometry in women with uncomplicated pregnancies and postpartum.
    van Rheenen-Flach LE; Zweegman S; Boersma F; Lenglet JE; Twisk JW; Bolte AC
    Aust N Z J Obstet Gynaecol; 2013 Feb; 53(1):32-6. PubMed ID: 23278445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen, red blood cells, and factor XIII in venous thrombosis.
    Walton BL; Byrnes JR; Wolberg AS
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(Suppl 1):S208-15. PubMed ID: 26149026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemostatic profile in patients with and without postpartum hemorrhage].
    Durán-Nah JJ; Sosa-Ek MV; Chacón-Hernández L
    Rev Med Inst Mex Seguro Soc; 2019 Mar; 56(6):517-524. PubMed ID: 30889339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen.
    Greenberg CS; Shuman MA
    J Biol Chem; 1982 Jun; 257(11):6096-101. PubMed ID: 7076665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution.
    Schramko AA; Kuitunen AH; Suojaranta-Ylinen RT; Niemi TT
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):731-5. PubMed ID: 19239406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.